Clinical Trial Detail

NCT ID NCT04067336
Title First in Human Study of KO-539 in Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kura Oncology, Inc.
Indications

acute myeloid leukemia

Therapies

KO-539

Age Groups: adult senior

No variant requirements are available.